[1]
OğulA. and BüyükşimşekM. 2020. Prognostic role of inflammatory markers in hepatocellular cancer patients receiving sorafenib therapy. Medical Science and Discovery. 7, 5 (May 2020), 475-481. DOI:https://doi.org/10.36472/msd.v7i5.374.